Clinical Trials Directory

Trials / Unknown

UnknownNCT02088346

Acute Stroke Advancing Program Using Telemedicine

Intravenous Thrombolysis Guided by Telemedicine Consultation System for Acute Ischemic Stroke Patients in China

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose is to evaluate the effectiveness and safety profile of telemedicine consultation system in making decision on IV thrombolysis.

Detailed description

The rate of intravenous thrombolysis with tissue-type plasminogen activator or urokinase for stroke patients was extremely low in China. It has been demonstrated that telestroke may help to increase the rate of intravenous thrombolysis and improve the stroke care quality in the local hospitals. The aim of this study is to evaluate the effectiveness and safety of decision making of intravenous thrombolysis via telemedicine consultation system for acute ischemic stroke patients in China This trial network consists of one hub hospital (Xijing Hospital) and 14 spoke hospitals in the remote area of Shanxi Province. The telemedicine consultation system is an interactive, 2-way, wireless, audiovisual system based on portable hardwares--tablet computer or smartphone. Before this study, we have been investigating the usual stroke care quality in the spoke hospitals without the guidance from the hub hospital, which will be used as the historical control of this study. After that, the teleconsultation system will be introduced.

Conditions

Interventions

TypeNameDescription
OTHERTelemedicine consultation systemTelemedicine consultation system based on portable hardwares

Timeline

Start date
2014-08-01
Primary completion
2015-08-01
Completion
2015-11-01
First posted
2014-03-14
Last updated
2015-06-25

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02088346. Inclusion in this directory is not an endorsement.